Literature DB >> 1899633

Experimental induction of heterotopic bone.

A Ekelund1, O Brosjö, O S Nilsson.   

Abstract

Heterotopic bone can be induced in experimental animals by trauma to the soft tissues, by induction from living cells, or by extracts from bone and teeth. In the first two types, the mechanism of the inductive process is not known, whereas in the latter, a factor isolated from bone matrix induces bone formation. Mesenchymal cells in bone marrow are determined for development into cartilage and bone cells and only an unspecific stimulus, such as trauma or autotransplantation, is sufficient for the development into mature osteogenic tissue. Mesenchymal cells will not differentiate into bone cells unless stimulated by a specific inductive substance, bone morphogenetic protein (BMP). Implanted to a heterotopic site, BMP induces undifferentiated mesenchymal cells into a bone morphogenetic pathway of development, causing heterotopic bone formation. The quantitative inductive response is dependent on the source of the BMP, and the bone formation is also determined by the recruitment of inducible target cells and by the environment at the implantation site. Hence, the environment at the implantation site is of major importance for the amount of bone formed. BMP initiates a cascade of events that is modulated by endocrine and paracrine factors. The heterotopic bone has all the morphologic and biochemical characteristics of orthotopic bone, is subjected to turnover, and even has the intriguing ability to generate the formation of bone marrow. Experimental induction of heterotopic bone has become a most useful method to study osteoneogenesis and has supplied important information on the prerequisites for new bone formation and on the regulation of bone metabolism.

Entities:  

Mesh:

Year:  1991        PMID: 1899633

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Does a plastic drape reduce incidence of heterotopic ossification after hip resurfacing?

Authors:  John S Shields; Ali Mofidi; William G Ward; Riyaz H Jinnah
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

2.  Osteogenic gene expression correlates with development of heterotopic ossification in war wounds.

Authors:  Korboi N Evans; Benjamin K Potter; Trevor S Brown; Thomas A Davis; Eric A Elster; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2013-10-18       Impact factor: 4.176

3.  Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro.

Authors:  Yu-suke Torisawa; Catherine S Spina; Tadanori Mammoto; Akiko Mammoto; James C Weaver; Tracy Tat; James J Collins; Donald E Ingber
Journal:  Nat Methods       Date:  2014-05-04       Impact factor: 28.547

4.  Aspirin decreases heterotopic ossification after hip resurfacing.

Authors:  Ryan M Nunley; Jinjun Zhu; John C Clohisy; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

5.  Amniotic membrane attenuates heterotopic ossification following high-dose bone morphogenetic protein-2 treatment of segmental bone defects.

Authors:  Lauren B Priddy; Laxminarayanan Krishnan; Marian H Hettiaratchi; Sukhita Karthikeyakannan; Nikhil Gupte; Robert E Guldberg
Journal:  J Orthop Res       Date:  2022-03-27       Impact factor: 3.102

6.  Does Postoperative Radiation Decrease Heterotopic Ossification After the Kocher-Langenbeck Approach for Acetabular Fracture?

Authors:  Jason A Davis; Brennan Roper; John W Munz; Timothy S Achor; Matthew Galpin; Andrew M Choo; Joshua L Gary
Journal:  Clin Orthop Relat Res       Date:  2016-06       Impact factor: 4.176

Review 7.  Intrathyroidal hematopoiesis: a rare histological finding in an otherwise healthy patient and review of the literature.

Authors:  Christina C Westhoff; Elias Karakas; Carsten Dietz; Peter J Barth
Journal:  Langenbecks Arch Surg       Date:  2008-02-26       Impact factor: 3.445

8.  Immunohistochemical characterization of the small proteoglycans decorin and proteoglycan-100 in heterotopic ossification.

Authors:  A Bosse; H Kresse; K Schwarz; K M Müller
Journal:  Calcif Tissue Int       Date:  1994-02       Impact factor: 4.333

9.  Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.

Authors:  Michele Barbato; Ezio D'Angelo; Giuseppina Di Loreto; Angelo Menna; Alexander Di Francesco; Vincenzo Salini; Umberto Zoppi; Lino Cavasinni; Pancrazio La Floresta; Carlo Luca Romanò
Journal:  J Orthop Traumatol       Date:  2012-02-23

10.  Experimental model of heterotopic ossification in Wistar rats.

Authors:  T G G Zotz; J B de Paula; A D L Moser
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.